I've been invested in this share since day 1.
The discrepancy between book value and market cap and the very tight implied passing yield give me reason to consider my position, with a bit of profit taking at these levels appealing. But I can't see the demand for childcare dropping anytime soon, plus the low gearing and lost cost of debt wont change in a hurry, so I find it difficult to pull the trigger. The divided is useful and robust. I think I've just talked myself into not selling any for now, but will review in 6-12 months time.
Best Est* 2021 FY 2021 HY 2020 FY 2020 HY 2019 FY 2019 HY 2018 FY 2017 FY 1 Property A 1,112.4 1,112.4 1,017.2 914.0 853.3 798.3 742.9 699.4 591.7 2 Other assets 39.1 39.1 45.1 98.6 37.1 27.4 20.8 26.7 29.6 3 Total assets 1,151.5 1,151.5 1,062.2 1,012.6 890.4 825.7 763.7 726.1 621.3 4 5 Borrowings 240.0 240.0 235.0 215.0 207.0 188.5 196.0 179.5 171.0 6 Other liabilities 32.6 32.6 32.8 45.7 30.5 26.9 16.5 15.0 17.8 7 Total liabilities 272.6 272.6 267.8 260.7 237.5 215.4 212.5 194.5 188.8 8 9 Net assets B 878.9 878.9 794.4 751.9 652.9 610.3 551.2 531.6 432.5 10 11 Securities on issue C 343.6 343.6 341.9 327.3 300.0 291.3 271.3 269.4 234.8 12 13 Passing yield D 5.8% 5.8% 6.1% 6.2% 6.3% 6.4% 6.5% 6.5% 6.8% 14 Gearing 20.8% 20.8% 22.1% 21.2% 23.2% 22.8% 25.7% 24.7% 27.5% 15 NAV $2.56 $2.56 $2.32 $2.30 $2.18 $2.10 $2.03 $1.97 $1.84 16 Share price E $4.17 $3.60 $2.88 $2.19 $2.85 $2.74 $2.41 $2.15 $2.25 17 18 Market capitalisation C x E = F $1,433.00 $1,237.12 $984.58 $716.74 $855.00 $798.16 $653.83 $579.21 $528.30 19 Valuation difference - Market cap to Net Assets - B = G $554.08 $358.20 $190.18 -$35.14 $202.10 $187.86 $102.63 $47.61 $95.80 20 (as %) G / B 63.0% 40.8% 23.9% -4.7% 31.0% 30.8% 18.6% 9.0% 22.2% 21 22 Property (implied) A + G = H $1,666.51 $1,470.63 $1,207.35 $878.87 $1,055.40 $986.16 $845.53 $747.01 $687.50 23 (as %) G / A 49.8% 32.2% 18.7% -3.8% 23.7% 23.5% 13.8% 6.8% 16.2% 24 25 Passing yield (implied) (A x D) / H 3.85% 4.36% 5.16% 6.47% 5.11% 5.16% 5.68% 6.10% 5.82% 26 27 Best Est* - Applies today's closing price to last reported figures
- Forums
- ASX - By Stock
- Ann: FY21 Annual Results Presentation
I've been invested in this share since day 1.The discrepancy...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.02 |
Change
-0.040(0.99%) |
Mkt cap ! $1.593B |
Open | High | Low | Value | Volume |
$3.95 | $4.06 | $3.95 | $1.304M | 324.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 9884 | $4.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.02 | 10406 | 38 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 6532 | 4.010 |
17 | 13075 | 4.000 |
12 | 17558 | 3.990 |
10 | 11410 | 3.980 |
9 | 24056 | 3.970 |
Price($) | Vol. | No. |
---|---|---|
4.020 | 11894 | 31 |
4.030 | 24481 | 22 |
4.040 | 16208 | 13 |
4.050 | 22432 | 10 |
4.060 | 9095 | 10 |
Last trade - 15.18pm 13/11/2024 (20 minute delay) ? |
Featured News
ARF (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online